amlodipine has been researched along with niacin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ha, MC; Kim, JS; Kim, KA; Lee, GH; Lee, OJ; O, MJ; Park, JH; Park, JY; Park, PW; Ryu, JH | 1 |
| Ahn, TH; Chung, N; Kim, SA; Lim, DS; Oh, BH; Park, S; Tahk, SJ; Yang, JY | 1 |
| Choi, DJ; Kang, HJ; Lee, HY; Oh, BH; Oh, GC; Zo, JH | 1 |
| Gan'shina, TS; Gnezdilova, AV; Gorbunov, AA; Kim, GA; Mirzoian, RS | 1 |
| Gan'shina, TS; Gnezdilova, AV; Kim, GA; Kurdiumov, IN; Mirzoian, RS | 1 |
| Bao, JJ; Fu, X; Li, Y; Liang, S; Xiao, H; Zhang, Y | 1 |
| Catterall, WA; Gamal El-Din, TM; Pryde, DC; Scheuer, T; Swanson, TM; Tang, L; Zheng, N | 1 |
| Chen, J; Jing, YH; Li, BQ; Wang, X; Xu, ML; Zhai, HL | 1 |
| Cho, KH; Cho, YS; Hwang, HH; Jang, CG; Kang, SY; Kim, HG; Lee, GH; Lee, SY; Lee, YJ; Lee, YY; Oh, MJ | 1 |
| Gao, YP; Han, F; Jiang, GJ; Liao, MH; Liu, QB; Lu, YM; Lyu, H; Wang, CK; Wang, P; Yang, L; Yao, KX | 1 |
| Fan, Y; Liu, F; Lu, Y; Wu, X; Yin, J | 1 |
| Chen, P; Cui, L; Cui, W; Dang, A; Dong, Y; Du, X; Duan, C; Gao, P; Hua, Q; Huo, Y; Jiang, Y; Li, J; Ma, W; Qi, X; Qu, P; Sun, N; Sun, Y; Wu, G; Xie, J; Zhao, L | 1 |
1 review(s) available for amlodipine and niacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for amlodipine and niacin
| Article | Year |
|---|---|
Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
Topics: Administration, Oral; Adult; Amlodipine; Analysis of Variance; Area Under Curve; Biological Availability; Blood Pressure; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cross-Over Studies; Electrocardiography; Half-Life; Heart Rate; Humans; Male; Mass Spectrometry; Metabolic Clearance Rate; Niacin; Therapeutic Equivalency; Time Factors | 2006 |
Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, ph
Topics: Adult; Aged; Amlodipine; Asian People; Double-Blind Method; Female; Humans; Male; Middle Aged; Niacin; Stereoisomerism | 2008 |
Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Female; Follow-Up Studies; Foot; Humans; Hypertension; Middle Aged; Niacin; Republic of Korea; Stereoisomerism | 2012 |
Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Asian People; Calcium Channel Blockers; Cross-Over Studies; Drug Combinations; Healthy Volunteers; Humans; Male; Niacin; Olmesartan Medoxomil; Tablets; Therapeutic Equivalency; Young Adult | 2017 |
Comparative effects of 2.5mg levamlodipine and 5mg amlodipine on vascular endothelial function and atherosclerosis.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atherosclerosis; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Niacin; Vasodilator Agents | 2019 |
Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; China; Comparative Effectiveness Research; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Niacin; Prospective Studies | 2021 |
9 other study(ies) available for amlodipine and niacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Comparative study of the effect of S-amlodipine nicotinate and amlodipine benzylate on the arterial pressure of awake rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Arterial Pressure; Calcium Channel Blockers; Niacin; Rats; Time Factors; Wakefulness | 2014 |
[Effect of S-amlodipine nicotinate on the cerebral circulation in rats under conditions of ischemic and hemorrhagic brain injury].
Topics: Amlodipine; Animals; Animals, Outbred Strains; Brain; Brain Edema; Brain Injuries; Brain Ischemia; Laser-Doppler Flowmetry; Male; Microcirculation; Niacin; Nimodipine; Rats; Vasodilator Agents | 2014 |
An approach to the determination of the enantiomeric excess at the extreme case by capillary electrophoresis.
Topics: Amlodipine; Electrophoresis, Capillary; Feasibility Studies; Niacin; Ofloxacin; Stereoisomerism; Tablets | 2015 |
Structural basis for inhibition of a voltage-gated Ca
Topics: Allosteric Regulation; Amines; Amlodipine; Animals; Bacterial Proteins; Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line; Crystallography, X-Ray; Dihydropyridines; Lipids; Models, Molecular; Moths; Mutation; Niacin; Protein Subunits; Verapamil | 2016 |
Krawtchouk image moment method for the simultaneous determination of three drugs in human plasma based on fluorescence three-dimensional spectra.
Topics: Amlodipine; Humans; Imaging, Three-Dimensional; Limit of Detection; Linear Models; Metoprolol; Models, Theoretical; Niacin; Reproducibility of Results; Spectrometry, Fluorescence | 2016 |
Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.
Topics: Amlodipine; Animals; Astrocytes; Blood Vessels; Dementia, Vascular; Disease Models, Animal; Mice; Microglia; Niacin; Nootropic Agents | 2019 |